May 28, 2020

The Latest

What’s Super about a Supercluster?

NGen CEO, Jayson Myers provides his thoughts on what makes the Superclusters “Super”

“A supercluster like NGen works to magnify the potential benefits of business clusters in a number of important ways.

NGen has a national mandate and a super-high level of ambition. Our sights are set on global excellence. We work to combine the best in terms of knowledge, technologies, and production capabilities from across Canada to develop unique solutions for Canadian manufacturers that can subsequently be commercialized in world markets. And, to promote Canada’s strengths in advanced manufacturing across the country and around the world.” Read More >

Becoming an Approved Supplier of Medical Devices

NGen will host a series of informative webinars entitled Becoming an Approved Supplier of Medical Devices, which are designed to help QMS-certified companies from other sectors understand the requirements of ISO 13485 Medical Device manufacture.

Canada is currently facing serious and significant challenges in obtaining the necessary PPE (personal protective equipment) and medical devices to protect the health of Canadians during the COVID-19 pandemic.  Canadian companies from all industries have stepped up to answer this need. Converting production lines across industry sectors from commercial, automotive or aerospace to medical devices is complex. Medical device manufacturing has unique regulatory and certification requirements.  Which elements of medical device manufacturing certification are unique and which are equivalent to elements of the IS09001, AS9100 (aerospace) and TS 16949 (automotive) standards?  These issues will be addressed in this three part series.

ISO 9001 to ISO 13485: Tuesday, June 16, 2020                 1:00 PM – 2:15 PM EST 

TS 16949 to ISO 13485: Wednesday, June 17, 2020          1:00 PM – 2:15 PM EST 

AS 9100 to ISO 13485: Thursday, June 18, 2020                1:00 PM – 2:15 PM EST 

Minister Bains announces Eclipse Automation's N95 Canadian mask design

The Honorable Navdeep Bains, Minister for Innovation, Science and Economic Development Canada, announces NGen's support for Eclipse Automation's efforts to retrofit traditional N95 machines to produce new mask designs with Canadian intellectual property. View here Bains-Eclipse-Annnouncement

Le ministre Bains annonce la conception du masque canadien N95 d'Eclipse Automation

L'honorable Navdeep Bains, ministre de l'Innovation, des Sciences et du Développement économique Canada, annonce le soutien de NGen aux efforts d'Eclipse Automation pour moderniser les machines N95 traditionnelles afin de produire de nouveaux modèles de masques canadiens dotés de la propriété intellectuelle canadienne. Voir ici
COVID-19 information

COVID-19: Resources for Canadian Businesses

The following resources are being compiled by NGen to help medical-licensed manufacturers provide a high-quality, rapid response to the COVID-19 pandemic.  

Critical Resource Bank

COVID-19 Capabilities

COVID-19 Project Application Guide

Government Resources

Resources for Manufacturers

Interim Order Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19

On May 23, 2020, Canada’s Minister of Health approved an Interim Order to respond to the urgent need for COVID-19 diagnosis, treatment, mitigation or prevention options. The Interim Order (IO) introduces a new pathway to facilitate the conduct of clinical trials in Canada to investigate and offer patients access to potential COVID-19 drugs and medical devices, while upholding strong patient safety requirements.

Arrêté d’urgence sur les essais cliniques d’instruments médicaux et de drogues en lien avec la COVID-19

Le 23 mai 2020, la ministre de la Santé du Canada a approuvé un Arrêté d’urgence sur les essais cliniques d’instruments médicaux et de drogues en lien avec la COVID-19 (l’Arrêté d’urgence) afin de répondre au besoin urgent d’options de diagnostic, de traitement, d’atténuation ou de prévention de la COVID-19. L’Arrêté d’urgence introduit une nouvelle voie pour faciliter la conduite des essais cliniques au Canada afin d’étudier et d’offrir aux patients l’accès à des médicaments et à des instruments médicaux potentiels contre la COVID-19, tout en respectant des exigences strictes en matière de sécurité des patients.

Online Events

Manufacturing during COVID-19: Ramping up again

Date: June 4, 2020
Time: 1:00 PM ET

This summit could not come at a more critical time. As jurisdictions across Canada start to reopen their economies, manufacturers need to be ready to ramp up.

But it won’t be business-as-usual, as COVID prevention measures will entail a host of new safety protocols, changes to logistics, contingency plans for future emergencies, and more.

To better understand the new normal, the Canadian Manufacturing team has assembled industry experts, trade association reps and professional advisors to discuss how to navigate these choppy waters. Register here

The Evolution of an Economic Engine: Assessing the State of Canadian Advanced Manufacturing

Date: June 5, 2020
Time: 12:00 PM ET

Join the following industry leaders as they examine how the country’s advanced manufacturing sector has responded to COVID-19 and assess the pandemic’s impact on the future of the sector.
Jayson Myers
Chief Executive Officer, Next Generation Manufacturing Canada
Diane Reko
President & Chief Executive Officer, Reko International Group Inc.
Flavio Volpe
President, Automotive Parts Manufacturers' Association (APMA)
Peter Hatges
Partner, National Sector Leader, Automotive, KPMG in Canada, & Managing Director KPMG Corporate Finance Inc. Register here
NGen Partners Corner

Manufacturer Partnerships are Answering the Call on the Ventilator Shortage

The hardware assembler and manufacturer Celestica, based in Toronto, Canada, has incorporated advanced design and process control to manufacturing in order to fabricate critical ventilators to address the needs of the COVID-19 pandemic. Celestica  announced it won a program to build 7,500 ventilators for StarFish Medical Inc., a Canadian medical device company, at Celestica’s factory operation in Newmarket, Ontario. StarFish. Read more_>

NGen is Still Open for Business 

NGen continues to support collaborative, industry-led projects intent on building world leading advanced manufacturing capabilities in Canada. 

Project applications are invited at 

To be eligible to apply for NGen Supercluster projects you need to be an NGen member, it is free. Join here

NGen est toujours en activité.

NGen continue d'appuyer les projets de collaboration dirigés par l'industrie qui visent à créer au Canada des capacités de fabrication de pointe de calibre mondial.

Nous vous invitons à présenter vos demandes de financement de projets à

Pour être éligible à postuler pour des projets NGen, vous devez être membre, c'est gratuit. Rejoignez-nous ici